High levels of serum estrogens are related to the development of estrogen receptor-positive (ER +) breast cancer and ovarian cancer, and therefore it can be speculated that GUS has a role in these cancer types (Hu et al. 2023; Kwa et al. 2016). Here, ESR1 is linked to ovarian carcinoma.